secwatch.observer — SEC 8-K summary
======================================

Issuer:     SS Innovations International, Inc. (SSII)
CIK:        0001676163
Form:       8-K
Filed at:   2024-08-22T23:59:59+00:00
Accession:  0001213900-24-071833
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

SS Innovations expands board to 7, appoints Dr. Frederic Moll (Intuitive Surgical co-founder) and Timothy Adams
--------------------------------------------------------------------------------

- Board expanded from 5 to 7 members; Dr. Frederic Moll appointed as director and non-executive Vice Chairman, effective August 20, 2024.
- Dr. Moll co-founded Intuitive Surgical and Auris Health; most recently Chief Development Officer at Johnson & Johnson Medical Devices (2019-2023).
- Timothy P. Adams appointed as director; current Regional Operating Officer at Ascension, overseeing high-growth horizontal business units.
- Both appointees deemed independent; compensation committee formed with Adams (Chair), Moll, and Dr. S.P. Somashekhar.
- Company cites their expertise in robotic surgery and U.S. healthcare as key to advancing FDA approval and market expansion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676163/000121390024071833/0001213900-24-071833-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676163/000121390024071833/ea0212126-8k_ssinnov.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-071833

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer